SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '3C0'
DrReposER ID / Desc. | Hit PDBID |
Hit Macromolecule |
Res. Matches |
Interface | HETATM | RMSD | Dali Z-score |
Seq. Identity (%) |
View | Dock | |
---|---|---|---|---|---|---|---|---|---|---|---|
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4DAJ_A_0HKA2000_1 (MUSCARINICACETYLCHOLINERECEPTOR M3,LYSOZYME) |
4u16 | MUSCARINICACETYLCHOLINERECEPTORM3,LYSOZYME,MUSCARINIC ACETYLCHOLINERECEPTOR M3 (EscherichiavirusT4;Rattusnorvegicus) | 12 / 12 | ASP A 147TYR A 148SER A 151ASN A 152TRP A 199THR A 231ALA A 238TRP A 503TYR A 506ASN A 507TYR A 529CYH A 532 | 3C0 A1202 (-3.4A)3C0 A1202 (-3.7A)3C0 A1202 (-2.9A)None3C0 A1202 (-4.4A)None3C0 A1202 (-3.5A)3C0 A1202 ( 4.0A)3C0 A1202 (-3.7A)3C0 A1202 (-2.9A)3C0 A1202 (-3.7A)3C0 A1202 (-3.6A) | 0.52A | 4dajA-4u16A:35.6 | 4dajA-4u16A:86.85 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4DAJ_A_0HKA2000_1 (MUSCARINICACETYLCHOLINERECEPTOR M3,LYSOZYME) |
4u16 | MUSCARINICACETYLCHOLINERECEPTORM3,LYSOZYME,MUSCARINIC ACETYLCHOLINERECEPTOR M3 (EscherichiavirusT4;Rattusnorvegicus) | 6 / 12 | ASP A 147TYR A 148THR A 234ASN A 507TYR A 529CYH A 532 | 3C0 A1202 (-3.4A)3C0 A1202 (-3.7A)None3C0 A1202 (-2.9A)3C0 A1202 (-3.7A)3C0 A1202 (-3.6A) | 1.44A | 4dajA-4u16A:35.6 | 4dajA-4u16A:86.85 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4DAJ_A_0HKA2000_1 (MUSCARINICACETYLCHOLINERECEPTOR M3,LYSOZYME) |
4u16 | MUSCARINICACETYLCHOLINERECEPTORM3,LYSOZYME,MUSCARINIC ACETYLCHOLINERECEPTOR M3 (EscherichiavirusT4;Rattusnorvegicus) | 5 / 12 | TYR A 148SER A 151ASN A 152TRP A 199TYR A 529 | 3C0 A1202 (-3.7A)3C0 A1202 (-2.9A)None3C0 A1202 (-4.4A)3C0 A1202 (-3.7A) | 1.36A | 4dajA-4u16A:35.6 | 4dajA-4u16A:86.85 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4DAJ_B_0HKB2000_1 (MUSCARINICACETYLCHOLINERECEPTOR M3,LYSOZYME) |
4u16 | MUSCARINICACETYLCHOLINERECEPTORM3,LYSOZYME,MUSCARINIC ACETYLCHOLINERECEPTOR M3 (EscherichiavirusT4;Rattusnorvegicus) | 12 / 12 | ASP A 147TYR A 148SER A 151TRP A 199THR A 231THR A 234ALA A 238TRP A 503TYR A 506ASN A 507TYR A 529CYH A 532 | 3C0 A1202 (-3.4A)3C0 A1202 (-3.7A)3C0 A1202 (-2.9A)3C0 A1202 (-4.4A)NoneNone3C0 A1202 (-3.5A)3C0 A1202 ( 4.0A)3C0 A1202 (-3.7A)3C0 A1202 (-2.9A)3C0 A1202 (-3.7A)3C0 A1202 (-3.6A) | 0.43A | 4dajB-4u16A:35.7 | 4dajB-4u16A:86.85 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4DAJ_B_0HKB2000_1 (MUSCARINICACETYLCHOLINERECEPTOR M3,LYSOZYME) |
4u16 | MUSCARINICACETYLCHOLINERECEPTORM3,LYSOZYME,MUSCARINIC ACETYLCHOLINERECEPTOR M3 (EscherichiavirusT4;Rattusnorvegicus) | 7 / 12 | ASP A 147TYR A 148THR A 231TRP A 503ASN A 507TYR A 529CYH A 532 | 3C0 A1202 (-3.4A)3C0 A1202 (-3.7A)None3C0 A1202 ( 4.0A)3C0 A1202 (-2.9A)3C0 A1202 (-3.7A)3C0 A1202 (-3.6A) | 1.33A | 4dajB-4u16A:35.7 | 4dajB-4u16A:86.85 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4DAJ_B_0HKB2000_1 (MUSCARINICACETYLCHOLINERECEPTOR M3,LYSOZYME) |
4u16 | MUSCARINICACETYLCHOLINERECEPTORM3,LYSOZYME,MUSCARINIC ACETYLCHOLINERECEPTOR M3 (EscherichiavirusT4;Rattusnorvegicus) | 5 / 12 | TYR A 148THR A 231ALA A 235TYR A 529CYH A 532 | 3C0 A1202 (-3.7A)None3C0 A1202 (-3.5A)3C0 A1202 (-3.7A)3C0 A1202 (-3.6A) | 1.40A | 4dajB-4u16A:35.7 | 4dajB-4u16A:86.85 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4DAJ_C_0HKC2000_1 (MUSCARINICACETYLCHOLINERECEPTOR M3,LYSOZYME) |
4u16 | MUSCARINICACETYLCHOLINERECEPTORM3,LYSOZYME,MUSCARINIC ACETYLCHOLINERECEPTOR M3 (EscherichiavirusT4;Rattusnorvegicus) | 12 / 12 | ASP A 147TYR A 148SER A 151ASN A 152TRP A 199THR A 231THR A 234TRP A 503TYR A 506ASN A 507TYR A 529CYH A 532 | 3C0 A1202 (-3.4A)3C0 A1202 (-3.7A)3C0 A1202 (-2.9A)None3C0 A1202 (-4.4A)NoneNone3C0 A1202 ( 4.0A)3C0 A1202 (-3.7A)3C0 A1202 (-2.9A)3C0 A1202 (-3.7A)3C0 A1202 (-3.6A) | 0.49A | 4dajC-4u16A:39.4 | 4dajC-4u16A:86.85 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4DAJ_C_0HKC2000_1 (MUSCARINICACETYLCHOLINERECEPTOR M3,LYSOZYME) |
4u16 | MUSCARINICACETYLCHOLINERECEPTORM3,LYSOZYME,MUSCARINIC ACETYLCHOLINERECEPTOR M3 (EscherichiavirusT4;Rattusnorvegicus) | 7 / 12 | ASP A 147TYR A 148THR A 234TRP A 503ASN A 507TYR A 529CYH A 532 | 3C0 A1202 (-3.4A)3C0 A1202 (-3.7A)None3C0 A1202 ( 4.0A)3C0 A1202 (-2.9A)3C0 A1202 (-3.7A)3C0 A1202 (-3.6A) | 1.37A | 4dajC-4u16A:39.4 | 4dajC-4u16A:86.85 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4DAJ_C_0HKC2000_1 (MUSCARINICACETYLCHOLINERECEPTOR M3,LYSOZYME) |
4u16 | MUSCARINICACETYLCHOLINERECEPTORM3,LYSOZYME,MUSCARINIC ACETYLCHOLINERECEPTOR M3 (EscherichiavirusT4;Rattusnorvegicus) | 5 / 12 | SER A 151ASN A 152TYR A 529TYR A 533CYH A 532 | 3C0 A1202 (-2.9A)None3C0 A1202 (-3.7A)3C0 A1202 (-4.5A)3C0 A1202 (-3.6A) | 1.40A | 4dajC-4u16A:39.4 | 4dajC-4u16A:86.85 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4DAJ_D_0HKD2000_1 (MUSCARINICACETYLCHOLINERECEPTOR M3,LYSOZYME) |
4u16 | MUSCARINICACETYLCHOLINERECEPTORM3,LYSOZYME,MUSCARINIC ACETYLCHOLINERECEPTOR M3 (EscherichiavirusT4;Rattusnorvegicus) | 12 / 12 | ASP A 147TYR A 148SER A 151ASN A 152TRP A 199THR A 231THR A 234TRP A 503TYR A 506ASN A 507TYR A 529CYH A 532 | 3C0 A1202 (-3.4A)3C0 A1202 (-3.7A)3C0 A1202 (-2.9A)None3C0 A1202 (-4.4A)NoneNone3C0 A1202 ( 4.0A)3C0 A1202 (-3.7A)3C0 A1202 (-2.9A)3C0 A1202 (-3.7A)3C0 A1202 (-3.6A) | 0.46A | 4dajD-4u16A:35.5 | 4dajD-4u16A:86.85 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4DAJ_D_0HKD2000_1 (MUSCARINICACETYLCHOLINERECEPTOR M3,LYSOZYME) |
4u16 | MUSCARINICACETYLCHOLINERECEPTORM3,LYSOZYME,MUSCARINIC ACETYLCHOLINERECEPTOR M3 (EscherichiavirusT4;Rattusnorvegicus) | 8 / 12 | ASP A 147TYR A 148SER A 151THR A 231TRP A 503ASN A 507TYR A 529CYH A 532 | 3C0 A1202 (-3.4A)3C0 A1202 (-3.7A)3C0 A1202 (-2.9A)None3C0 A1202 ( 4.0A)3C0 A1202 (-2.9A)3C0 A1202 (-3.7A)3C0 A1202 (-3.6A) | 1.40A | 4dajD-4u16A:35.5 | 4dajD-4u16A:86.85 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4DAJ_D_0HKD2000_1 (MUSCARINICACETYLCHOLINERECEPTOR M3,LYSOZYME) |
4u16 | MUSCARINICACETYLCHOLINERECEPTORM3,LYSOZYME,MUSCARINIC ACETYLCHOLINERECEPTOR M3 (EscherichiavirusT4;Rattusnorvegicus) | 6 / 12 | TYR A 148SER A 151ASN A 152TRP A 199TRP A 503TYR A 529 | 3C0 A1202 (-3.7A)3C0 A1202 (-2.9A)None3C0 A1202 (-4.4A)3C0 A1202 ( 4.0A)3C0 A1202 (-3.7A) | 1.48A | 4dajD-4u16A:35.5 | 4dajD-4u16A:86.85 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4U14_A_0HKA2000_1 (MUSCARINICACETYLCHOLINERECEPTORM3,ENDOLYSIN,MUSCARINIC ACETYLCHOLINERECEPTOR M3) |
4u16 | MUSCARINICACETYLCHOLINERECEPTORM3,LYSOZYME,MUSCARINIC ACETYLCHOLINERECEPTOR M3 (EscherichiavirusT4;Rattusnorvegicus) | 6 / 12 | ASP A 147TYR A 148THR A 234ALA A 238TYR A 529CYH A 532 | 3C0 A1202 (-3.4A)3C0 A1202 (-3.7A)None3C0 A1202 (-3.5A)3C0 A1202 (-3.7A)3C0 A1202 (-3.6A) | 1.26A | 4u14A-4u16A:36.2 | 4u14A-4u16A:89.59 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4U14_A_0HKA2000_1 (MUSCARINICACETYLCHOLINERECEPTORM3,ENDOLYSIN,MUSCARINIC ACETYLCHOLINERECEPTOR M3) |
4u16 | MUSCARINICACETYLCHOLINERECEPTORM3,LYSOZYME,MUSCARINIC ACETYLCHOLINERECEPTOR M3 (EscherichiavirusT4;Rattusnorvegicus) | 12 / 12 | ILE A 116ASP A 147TYR A 148SER A 151TRP A 199THR A 231ALA A 235ALA A 238TRP A 503ASN A 507TYR A 529CYH A 532 | None3C0 A1202 (-3.4A)3C0 A1202 (-3.7A)3C0 A1202 (-2.9A)3C0 A1202 (-4.4A)None3C0 A1202 (-3.5A)3C0 A1202 (-3.5A)3C0 A1202 ( 4.0A)3C0 A1202 (-2.9A)3C0 A1202 (-3.7A)3C0 A1202 (-3.6A) | 0.47A | 4u14A-4u16A:36.2 | 4u14A-4u16A:89.59 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4U14_A_0HKA2000_1 (MUSCARINICACETYLCHOLINERECEPTORM3,ENDOLYSIN,MUSCARINIC ACETYLCHOLINERECEPTOR M3) |
4u16 | MUSCARINICACETYLCHOLINERECEPTORM3,LYSOZYME,MUSCARINIC ACETYLCHOLINERECEPTOR M3 (EscherichiavirusT4;Rattusnorvegicus) | 7 / 12 | ILE A 116ASP A 147TYR A 148THR A 234ASN A 507TYR A 529CYH A 532 | None3C0 A1202 (-3.4A)3C0 A1202 (-3.7A)None3C0 A1202 (-2.9A)3C0 A1202 (-3.7A)3C0 A1202 (-3.6A) | 1.38A | 4u14A-4u16A:36.2 | 4u14A-4u16A:89.59 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4U14_A_0HKA2000_2 (MUSCARINICACETYLCHOLINERECEPTORM3,ENDOLYSIN,MUSCARINIC ACETYLCHOLINERECEPTOR M3) |
4u16 | MUSCARINICACETYLCHOLINERECEPTORM3,LYSOZYME,MUSCARINIC ACETYLCHOLINERECEPTOR M3 (EscherichiavirusT4;Rattusnorvegicus) | 4 / 4 | ASN A 152LEU A 225PHE A 239TYR A 506 | NoneNoneNone3C0 A1202 (-3.7A) | 0.43A | 4u14A-4u16A:36.2 | 4u14A-4u16A:89.59 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4U15_A_0HKA2001_1 (MUSCARINICACETYLCHOLINERECEPTORM3,LYSOZYME,MUSCARINIC ACETYLCHOLINERECEPTOR M3) |
4u16 | MUSCARINICACETYLCHOLINERECEPTORM3,LYSOZYME,MUSCARINIC ACETYLCHOLINERECEPTOR M3 (EscherichiavirusT4;Rattusnorvegicus) | 11 / 12 | ASP A 147TYR A 148SER A 151THR A 231THR A 234ALA A 235ALA A 238TRP A 503ASN A 507TYR A 529CYH A 532 | 3C0 A1202 (-3.4A)3C0 A1202 (-3.7A)3C0 A1202 (-2.9A)NoneNone3C0 A1202 (-3.5A)3C0 A1202 (-3.5A)3C0 A1202 ( 4.0A)3C0 A1202 (-2.9A)3C0 A1202 (-3.7A)3C0 A1202 (-3.6A) | 0.56A | 4u15A-4u16A:50.6 | 4u15A-4u16A:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4U15_A_0HKA2001_1 (MUSCARINICACETYLCHOLINERECEPTORM3,LYSOZYME,MUSCARINIC ACETYLCHOLINERECEPTOR M3) |
4u16 | MUSCARINICACETYLCHOLINERECEPTORM3,LYSOZYME,MUSCARINIC ACETYLCHOLINERECEPTOR M3 (EscherichiavirusT4;Rattusnorvegicus) | 6 / 12 | ASP A 147TYR A 148THR A 231ALA A 235TYR A 529CYH A 532 | 3C0 A1202 (-3.4A)3C0 A1202 (-3.7A)None3C0 A1202 (-3.5A)3C0 A1202 (-3.7A)3C0 A1202 (-3.6A) | 1.34A | 4u15A-4u16A:50.6 | 4u15A-4u16A:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4U15_A_0HKA2001_1 (MUSCARINICACETYLCHOLINERECEPTORM3,LYSOZYME,MUSCARINIC ACETYLCHOLINERECEPTOR M3) |
4u16 | MUSCARINICACETYLCHOLINERECEPTORM3,LYSOZYME,MUSCARINIC ACETYLCHOLINERECEPTOR M3 (EscherichiavirusT4;Rattusnorvegicus) | 7 / 12 | ASP A 147TYR A 148THR A 231TRP A 503ASN A 507TYR A 529CYH A 532 | 3C0 A1202 (-3.4A)3C0 A1202 (-3.7A)None3C0 A1202 ( 4.0A)3C0 A1202 (-2.9A)3C0 A1202 (-3.7A)3C0 A1202 (-3.6A) | 1.34A | 4u15A-4u16A:50.6 | 4u15A-4u16A:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4U15_A_0HKA2001_1 (MUSCARINICACETYLCHOLINERECEPTORM3,LYSOZYME,MUSCARINIC ACETYLCHOLINERECEPTOR M3) |
4u16 | MUSCARINICACETYLCHOLINERECEPTORM3,LYSOZYME,MUSCARINIC ACETYLCHOLINERECEPTOR M3 (EscherichiavirusT4;Rattusnorvegicus) | 6 / 12 | ASP A 147TYR A 148THR A 234ALA A 238TYR A 529CYH A 532 | 3C0 A1202 (-3.4A)3C0 A1202 (-3.7A)None3C0 A1202 (-3.5A)3C0 A1202 (-3.7A)3C0 A1202 (-3.6A) | 1.37A | 4u15A-4u16A:50.6 | 4u15A-4u16A:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4U15_A_0HKA2001_1 (MUSCARINICACETYLCHOLINERECEPTORM3,LYSOZYME,MUSCARINIC ACETYLCHOLINERECEPTOR M3) |
4u16 | MUSCARINICACETYLCHOLINERECEPTORM3,LYSOZYME,MUSCARINIC ACETYLCHOLINERECEPTOR M3 (EscherichiavirusT4;Rattusnorvegicus) | 11 / 12 | ASP A 147TYR A 148TRP A 199THR A 231THR A 234ALA A 235ALA A 238TRP A 503ASN A 507TYR A 529CYH A 532 | 3C0 A1202 (-3.4A)3C0 A1202 (-3.7A)3C0 A1202 (-4.4A)NoneNone3C0 A1202 (-3.5A)3C0 A1202 (-3.5A)3C0 A1202 ( 4.0A)3C0 A1202 (-2.9A)3C0 A1202 (-3.7A)3C0 A1202 (-3.6A) | 0.40A | 4u15A-4u16A:50.6 | 4u15A-4u16A:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4U15_A_0HKA2001_2 (MUSCARINICACETYLCHOLINERECEPTORM3,LYSOZYME,MUSCARINIC ACETYLCHOLINERECEPTOR M3) |
4u16 | MUSCARINICACETYLCHOLINERECEPTORM3,LYSOZYME,MUSCARINIC ACETYLCHOLINERECEPTOR M3 (EscherichiavirusT4;Rattusnorvegicus) | 3 / 3 | ASN A 152PHE A 239TYR A 506 | NoneNone3C0 A1202 (-3.7A) | 0.40A | 4u15A-4u16A:50.6 | 4u15A-4u16A:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4U15_B_0HKB1201_1 (MUSCARINICACETYLCHOLINERECEPTORM3,LYSOZYME,MUSCARINIC ACETYLCHOLINERECEPTOR M3) |
4u16 | MUSCARINICACETYLCHOLINERECEPTORM3,LYSOZYME,MUSCARINIC ACETYLCHOLINERECEPTOR M3 (EscherichiavirusT4;Rattusnorvegicus) | 12 / 12 | ASP A 147TYR A 148SER A 151THR A 231THR A 234ALA A 235ALA A 238TRP A 503TYR A 506ASN A 507TYR A 529CYH A 532 | 3C0 A1202 (-3.4A)3C0 A1202 (-3.7A)3C0 A1202 (-2.9A)NoneNone3C0 A1202 (-3.5A)3C0 A1202 (-3.5A)3C0 A1202 ( 4.0A)3C0 A1202 (-3.7A)3C0 A1202 (-2.9A)3C0 A1202 (-3.7A)3C0 A1202 (-3.6A) | 0.42A | 4u15B-4u16A:47.3 | 4u15B-4u16A:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4U15_B_0HKB1201_1 (MUSCARINICACETYLCHOLINERECEPTORM3,LYSOZYME,MUSCARINIC ACETYLCHOLINERECEPTOR M3) |
4u16 | MUSCARINICACETYLCHOLINERECEPTORM3,LYSOZYME,MUSCARINIC ACETYLCHOLINERECEPTOR M3 (EscherichiavirusT4;Rattusnorvegicus) | 7 / 12 | ASP A 147TYR A 148SER A 151THR A 231TRP A 503ASN A 507CYH A 532 | 3C0 A1202 (-3.4A)3C0 A1202 (-3.7A)3C0 A1202 (-2.9A)None3C0 A1202 ( 4.0A)3C0 A1202 (-2.9A)3C0 A1202 (-3.6A) | 1.31A | 4u15B-4u16A:47.3 | 4u15B-4u16A:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4U15_B_0HKB1201_1 (MUSCARINICACETYLCHOLINERECEPTORM3,LYSOZYME,MUSCARINIC ACETYLCHOLINERECEPTOR M3) |
4u16 | MUSCARINICACETYLCHOLINERECEPTORM3,LYSOZYME,MUSCARINIC ACETYLCHOLINERECEPTOR M3 (EscherichiavirusT4;Rattusnorvegicus) | 5 / 12 | ASP A 147TYR A 148THR A 234ALA A 238CYH A 532 | 3C0 A1202 (-3.4A)3C0 A1202 (-3.7A)None3C0 A1202 (-3.5A)3C0 A1202 (-3.6A) | 1.22A | 4u15B-4u16A:47.3 | 4u15B-4u16A:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4U15_B_0HKB1201_1 (MUSCARINICACETYLCHOLINERECEPTORM3,LYSOZYME,MUSCARINIC ACETYLCHOLINERECEPTOR M3) |
4u16 | MUSCARINICACETYLCHOLINERECEPTORM3,LYSOZYME,MUSCARINIC ACETYLCHOLINERECEPTOR M3 (EscherichiavirusT4;Rattusnorvegicus) | 7 / 12 | ASP A 147TYR A 148THR A 234TRP A 503ASN A 507TYR A 529CYH A 532 | 3C0 A1202 (-3.4A)3C0 A1202 (-3.7A)None3C0 A1202 ( 4.0A)3C0 A1202 (-2.9A)3C0 A1202 (-3.7A)3C0 A1202 (-3.6A) | 1.39A | 4u15B-4u16A:47.3 | 4u15B-4u16A:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4U15_B_0HKB1201_2 (MUSCARINICACETYLCHOLINERECEPTORM3,LYSOZYME,MUSCARINIC ACETYLCHOLINERECEPTOR M3) |
4u16 | MUSCARINICACETYLCHOLINERECEPTORM3,LYSOZYME,MUSCARINIC ACETYLCHOLINERECEPTOR M3 (EscherichiavirusT4;Rattusnorvegicus) | 4 / 4 | ASN A 152TRP A 199LEU A 225PHE A 239 | None3C0 A1202 (-4.4A)NoneNone | 0.53A | 4u15B-4u16A:47.3 | 4u15B-4u16A:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5CXV_A_0HKA501_1 (MUSCARINICACETYLCHOLINERECEPTORM1,ENDOLYSIN,MUSCARINIC ACETYLCHOLINERECEPTOR M1) |
4u16 | MUSCARINICACETYLCHOLINERECEPTORM3,LYSOZYME,MUSCARINIC ACETYLCHOLINERECEPTOR M3 (EscherichiavirusT4;Rattusnorvegicus) | 10 / 12 | ASP A 147TYR A 148SER A 151ALA A 235ALA A 238TRP A 503TYR A 506ASN A 507TYR A 529CYH A 532 | 3C0 A1202 (-3.4A)3C0 A1202 (-3.7A)3C0 A1202 (-2.9A)3C0 A1202 (-3.5A)3C0 A1202 (-3.5A)3C0 A1202 ( 4.0A)3C0 A1202 (-3.7A)3C0 A1202 (-2.9A)3C0 A1202 (-3.7A)3C0 A1202 (-3.6A) | 0.58A | 5cxvA-4u16A:39.2 | 5cxvA-4u16A:67.80 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5CXV_A_0HKA501_1 (MUSCARINICACETYLCHOLINERECEPTORM1,ENDOLYSIN,MUSCARINIC ACETYLCHOLINERECEPTOR M1) |
4u16 | MUSCARINICACETYLCHOLINERECEPTORM3,LYSOZYME,MUSCARINIC ACETYLCHOLINERECEPTOR M3 (EscherichiavirusT4;Rattusnorvegicus) | 10 / 12 | ASP A 147TYR A 148SER A 151TRP A 199ALA A 235TRP A 503TYR A 506ASN A 507TYR A 529CYH A 532 | 3C0 A1202 (-3.4A)3C0 A1202 (-3.7A)3C0 A1202 (-2.9A)3C0 A1202 (-4.4A)3C0 A1202 (-3.5A)3C0 A1202 ( 4.0A)3C0 A1202 (-3.7A)3C0 A1202 (-2.9A)3C0 A1202 (-3.7A)3C0 A1202 (-3.6A) | 0.66A | 5cxvA-4u16A:39.2 | 5cxvA-4u16A:67.80 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5CXV_A_0HKA501_1 (MUSCARINICACETYLCHOLINERECEPTORM1,ENDOLYSIN,MUSCARINIC ACETYLCHOLINERECEPTOR M1) |
4u16 | MUSCARINICACETYLCHOLINERECEPTORM3,LYSOZYME,MUSCARINIC ACETYLCHOLINERECEPTOR M3 (EscherichiavirusT4;Rattusnorvegicus) | 5 / 12 | ASP A 147TYR A 148TRP A 199ALA A 238CYH A 532 | 3C0 A1202 (-3.4A)3C0 A1202 (-3.7A)3C0 A1202 (-4.4A)3C0 A1202 (-3.5A)3C0 A1202 (-3.6A) | 1.28A | 5cxvA-4u16A:39.2 | 5cxvA-4u16A:67.80 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5DSG_A_0HKA1201_1 (MUSCARINICACETYLCHOLINERECEPTORM4,ENDOLYSIN,ENDOLYSIN,MUSCARINICACETYLCHOLINERECEPTOR M4) |
4u16 | MUSCARINICACETYLCHOLINERECEPTORM3,LYSOZYME,MUSCARINIC ACETYLCHOLINERECEPTOR M3 (EscherichiavirusT4;Rattusnorvegicus) | 5 / 12 | ASP A 147TYR A 148ALA A 235TYR A 529CYH A 532 | 3C0 A1202 (-3.4A)3C0 A1202 (-3.7A)3C0 A1202 (-3.5A)3C0 A1202 (-3.7A)3C0 A1202 (-3.6A) | 1.47A | 5dsgA-4u16A:40.8 | 5dsgA-4u16A:75.41 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5DSG_A_0HKA1201_1 (MUSCARINICACETYLCHOLINERECEPTORM4,ENDOLYSIN,ENDOLYSIN,MUSCARINICACETYLCHOLINERECEPTOR M4) |
4u16 | MUSCARINICACETYLCHOLINERECEPTORM3,LYSOZYME,MUSCARINIC ACETYLCHOLINERECEPTOR M3 (EscherichiavirusT4;Rattusnorvegicus) | 11 / 12 | ASP A 147TYR A 148SER A 151TRP A 199THR A 231ALA A 238TRP A 503TYR A 506ASN A 507TYR A 529CYH A 532 | 3C0 A1202 (-3.4A)3C0 A1202 (-3.7A)3C0 A1202 (-2.9A)3C0 A1202 (-4.4A)None3C0 A1202 (-3.5A)3C0 A1202 ( 4.0A)3C0 A1202 (-3.7A)3C0 A1202 (-2.9A)3C0 A1202 (-3.7A)3C0 A1202 (-3.6A) | 0.73A | 5dsgA-4u16A:40.8 | 5dsgA-4u16A:75.41 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5DSG_A_0HKA1201_1 (MUSCARINICACETYLCHOLINERECEPTORM4,ENDOLYSIN,ENDOLYSIN,MUSCARINICACETYLCHOLINERECEPTOR M4) |
4u16 | MUSCARINICACETYLCHOLINERECEPTORM3,LYSOZYME,MUSCARINIC ACETYLCHOLINERECEPTOR M3 (EscherichiavirusT4;Rattusnorvegicus) | 5 / 12 | ASP A 147TYR A 148THR A 231ALA A 235CYH A 532 | 3C0 A1202 (-3.4A)3C0 A1202 (-3.7A)None3C0 A1202 (-3.5A)3C0 A1202 (-3.6A) | 1.44A | 5dsgA-4u16A:40.8 | 5dsgA-4u16A:75.41 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5DSG_A_0HKA1201_1 (MUSCARINICACETYLCHOLINERECEPTORM4,ENDOLYSIN,ENDOLYSIN,MUSCARINICACETYLCHOLINERECEPTOR M4) |
4u16 | MUSCARINICACETYLCHOLINERECEPTORM3,LYSOZYME,MUSCARINIC ACETYLCHOLINERECEPTOR M3 (EscherichiavirusT4;Rattusnorvegicus) | 6 / 12 | ASP A 147TYR A 148THR A 231TRP A 503ASN A 507CYH A 532 | 3C0 A1202 (-3.4A)3C0 A1202 (-3.7A)None3C0 A1202 ( 4.0A)3C0 A1202 (-2.9A)3C0 A1202 (-3.6A) | 1.40A | 5dsgA-4u16A:40.8 | 5dsgA-4u16A:75.41 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5DSG_A_0HKA1201_1 (MUSCARINICACETYLCHOLINERECEPTORM4,ENDOLYSIN,ENDOLYSIN,MUSCARINICACETYLCHOLINERECEPTOR M4) |
4u16 | MUSCARINICACETYLCHOLINERECEPTORM3,LYSOZYME,MUSCARINIC ACETYLCHOLINERECEPTOR M3 (EscherichiavirusT4;Rattusnorvegicus) | 6 / 12 | ASP A 147TYR A 148THR A 234ASN A 507TYR A 529CYH A 532 | 3C0 A1202 (-3.4A)3C0 A1202 (-3.7A)None3C0 A1202 (-2.9A)3C0 A1202 (-3.7A)3C0 A1202 (-3.6A) | 1.49A | 5dsgA-4u16A:40.8 | 5dsgA-4u16A:75.41 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5DSG_A_0HKA1201_1 (MUSCARINICACETYLCHOLINERECEPTORM4,ENDOLYSIN,ENDOLYSIN,MUSCARINICACETYLCHOLINERECEPTOR M4) |
4u16 | MUSCARINICACETYLCHOLINERECEPTORM3,LYSOZYME,MUSCARINIC ACETYLCHOLINERECEPTOR M3 (EscherichiavirusT4;Rattusnorvegicus) | 11 / 12 | ASP A 147TYR A 148TRP A 199THR A 231THR A 234ALA A 238TRP A 503TYR A 506ASN A 507TYR A 529CYH A 532 | 3C0 A1202 (-3.4A)3C0 A1202 (-3.7A)3C0 A1202 (-4.4A)NoneNone3C0 A1202 (-3.5A)3C0 A1202 ( 4.0A)3C0 A1202 (-3.7A)3C0 A1202 (-2.9A)3C0 A1202 (-3.7A)3C0 A1202 (-3.6A) | 0.59A | 5dsgA-4u16A:40.8 | 5dsgA-4u16A:75.41 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5DSG_B_0HKB1201_1 (MUSCARINICACETYLCHOLINERECEPTORM4,ENDOLYSIN,ENDOLYSIN,MUSCARINICACETYLCHOLINERECEPTOR M4) |
4u16 | MUSCARINICACETYLCHOLINERECEPTORM3,LYSOZYME,MUSCARINIC ACETYLCHOLINERECEPTOR M3 (EscherichiavirusT4;Rattusnorvegicus) | 5 / 12 | LEU A 144TRP A 503TYR A 529TYR A 533CYH A 532 | None3C0 A1202 ( 4.0A)3C0 A1202 (-3.7A)3C0 A1202 (-4.5A)3C0 A1202 (-3.6A) | 1.46A | 5dsgB-4u16A:42.6 | 5dsgB-4u16A:75.41 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5DSG_B_0HKB1201_1 (MUSCARINICACETYLCHOLINERECEPTORM4,ENDOLYSIN,ENDOLYSIN,MUSCARINICACETYLCHOLINERECEPTOR M4) |
4u16 | MUSCARINICACETYLCHOLINERECEPTORM3,LYSOZYME,MUSCARINIC ACETYLCHOLINERECEPTOR M3 (EscherichiavirusT4;Rattusnorvegicus) | 11 / 12 | TYR A 148SER A 151TRP A 199LEU A 225THR A 231ALA A 238TRP A 503TYR A 506ASN A 507TYR A 529CYH A 532 | 3C0 A1202 (-3.7A)3C0 A1202 (-2.9A)3C0 A1202 (-4.4A)NoneNone3C0 A1202 (-3.5A)3C0 A1202 ( 4.0A)3C0 A1202 (-3.7A)3C0 A1202 (-2.9A)3C0 A1202 (-3.7A)3C0 A1202 (-3.6A) | 0.68A | 5dsgB-4u16A:42.6 | 5dsgB-4u16A:75.41 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5DSG_B_0HKB1201_1 (MUSCARINICACETYLCHOLINERECEPTORM4,ENDOLYSIN,ENDOLYSIN,MUSCARINICACETYLCHOLINERECEPTOR M4) |
4u16 | MUSCARINICACETYLCHOLINERECEPTORM3,LYSOZYME,MUSCARINIC ACETYLCHOLINERECEPTOR M3 (EscherichiavirusT4;Rattusnorvegicus) | 11 / 12 | TYR A 148TRP A 199LEU A 225THR A 231THR A 234ALA A 238TRP A 503TYR A 506ASN A 507TYR A 529CYH A 532 | 3C0 A1202 (-3.7A)3C0 A1202 (-4.4A)NoneNoneNone3C0 A1202 (-3.5A)3C0 A1202 ( 4.0A)3C0 A1202 (-3.7A)3C0 A1202 (-2.9A)3C0 A1202 (-3.7A)3C0 A1202 (-3.6A) | 0.54A | 5dsgB-4u16A:42.6 | 5dsgB-4u16A:75.41 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5DSG_B_0HKB1201_2 (MUSCARINICACETYLCHOLINERECEPTORM4,ENDOLYSIN,ENDOLYSIN,MUSCARINICACETYLCHOLINERECEPTOR M4) |
4u16 | MUSCARINICACETYLCHOLINERECEPTORM3,LYSOZYME,MUSCARINIC ACETYLCHOLINERECEPTOR M3 (EscherichiavirusT4;Rattusnorvegicus) | 3 / 3 | ASP A 147ASN A 152PHE A 239 | 3C0 A1202 (-3.4A)NoneNone | 0.66A | 5dsgB-4u16A:42.6 | 5dsgB-4u16A:75.41 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6DRX_A_H8GA1201_0 (5HT2B RECEPTOR, BRILCHIMERA) |
4u16 | MUSCARINICACETYLCHOLINERECEPTORM3,LYSOZYME,MUSCARINIC ACETYLCHOLINERECEPTOR M3 (Rattusnorvegicus;EscherichiavirusT4) | 5 / 12 | TRP A 143LEU A 144SER A 151ALA A 238TRP A 503 | NoneNone3C0 A1202 (-2.9A)3C0 A1202 (-3.5A)3C0 A1202 ( 4.0A) | 1.46A | 6drxA-4u16A:25.6 | 6drxA-4u16A:29.23 |